What this guide is best for
Direct answer: Use this guide when the delivery format is the main decision.
Best used when: The right format depends on routine, tolerance, consistency, and how easy it is for you to stay on plan.
TRT format choices
Key point: The right format depends on routine, tolerance, consistency, and how easy it is for you to stay on plan.
What a good provider should make clear: A good clinic should explain the tradeoffs of both formats instead of pretending one is always best.
Common mistake: Picking the format that sounds easiest without asking how it works in real life.
Questions to ask: Ask how each option affects routine, dose changes, follow-up, and what happens if the first format is not a good fit.
TRT format choices
Opening intent: compare the tradeoffs before deciding based on one factor
| Decision factor | What to compare |
|---|---|
| Best use case | Use this guide when the delivery format is the main decision. |
| Main tradeoff | The right format depends on routine, tolerance, consistency, and how easy it is for you to stay on plan. |
| Common mistake | Picking the format that sounds easiest without asking how it works in real life. |
| Question to ask | Ask how each option affects routine, dose changes, follow-up, and what happens if the first format is not a good fit. |
Quick answer
Which delivery method suits you is a clinical decision, and this page will not make it. What it can do is show you which of the three has a published price and which does not, because that changes what a clinic can charge you without anyone being able to check it.
Two of the three involve a clinician doing something billable. One does not. That single fact explains most of what is confusing about comparing quotes.
What is published for each delivery method
National Medicare figures, office setting, calendar year 2024.
| Delivery method | Billable clinician procedure | Average submitted charge | Average Medicare allowed | Clinicians who billed it |
|---|---|---|---|---|
| Injection administered in a clinic | 96372 — injection under the skin or into muscle | $55.33 | $13.42 | 215,456 |
| Pellet | 11980 — hormone pellet placement under the skin | $274.77 | $86.79 | 2,039 |
| Gel or other topical | None in this dataset | Not published | Not published | Not published |
No clinician-administered procedure code for applying a topical hormone appears in this file, so there is no published figure for it. That is not a comment on the product. It is a comment on what can be checked.
The medication itself is absent for all three. This dataset covers services clinicians bill, not drugs dispensed by a pharmacy.
So for a topical, essentially the entire cost sits in two places that are not published anywhere: the drug and the clinic's own fee. For an injection or a pellet, one component has a public reference price and the rest does not.
What the pellet row is worth reading twice
Pellet placement was billed at $274.77 on average and allowed at $86.79, roughly a three-fold gap, across 2,039 clinicians nationally. Injection was billed at $55.33 and allowed at $13.42, across 215,456.
Those provider counts are the more interesting number. Pellet placement is done by a small fraction of the clinicians who give injections. If a programme is built around pellets, ask how many the clinician has placed and how often you would return.
Beyond that, ask which measurements are repeated, at what interval, who reviews them, and what result would change the plan. A programme that does not repeat anything is not monitoring anything, whichever method it uses.
The comparison this page will not make for you
How each method behaves in a particular person — how often it is given, how it is absorbed, what it does to any given measurement — is a clinical question. We have not found a public source that would let us answer it honestly for a general reader, so we do not answer it.
Take it to the prescribing clinician, and take these questions with you: why this method rather than the other two, what would make you switch me, and what does switching cost.
Ask directly whether your problem is being treated as hormonal or as something else. A provider who will not say which has not assessed you.
Questions worth asking before you choose
- Which billing codes will appear on my claim for this method?
- Is the medication inside the quoted fee, or billed separately by a pharmacy?
- Is what you are prescribing an FDA-approved product or a compounded preparation?
- What is the one-off starting cost and what is the ongoing monthly cost, as two separate numbers?
- What labs are drawn before starting, and how often are they repeated in the first year?
- What does it cost to stop, or to switch to a different method, after three months?
On the compounding question, the FDA is explicit: "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." A compounded product has neither a published price nor an FDA review behind it.
Common mistake: comparing one clinic's monthly figure with another's without establishing that the two figures contain the same things.
Red flags
A method presented as obviously better with no mention of what it costs to reverse. A quoted package that never separates the drug from the procedure from the clinic fee. A prepaid year bought before the first repeat lab. A pellet programme that will not say how many placements the clinician has done.
Where these numbers come from, and what they are not
Source: Centers for Medicare & Medicaid Services, Medicare Physician & Other Practitioners — by Geography and Service, calendar year 2024 claims (file released 21 May 2026).
Method: we pull the published rows for each billing code in the office place of service and print them unchanged. Nothing is modelled, averaged across codes, or adjusted.
- The submitted charge is what clinicians billed. It is list price. Almost nobody pays it.
- The allowed amount is what Medicare permitted, including the patient's coinsurance. It is a negotiated price.
- These are Medicare fee-for-service claims. The patients skew 65 and older.
- If you are paying cash or using commercial insurance, neither figure is your price. Use the gap between them as a bargaining range, not a quote.
- CMS hides any cell covering fewer than 11 patients, so some states are missing. We print "not published" there rather than guessing.
- The dataset covers services clinicians bill. It does not cover drugs dispensed by a pharmacy, so no hormone product appears in it at any price.
What to do next
Get an itemised quote for two of the three methods from the same clinic, in writing, and hold the procedure line against the table above. Then take the clinical question — which one is right for you — to the prescriber, not to a price page.
Educational only. Not medical advice. No endorsements or rankings.